# Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

> **NCT05579847** · — · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 20 (actual)

## Conditions studied

- Renal Cell Carcinoma Stage IV

## Interventions

- **OTHER:** mHealth Smart Phone Application
- **BEHAVIORAL:** eHEALS digital literacy test
- **BEHAVIORAL:** Weekly Quiz
- **BEHAVIORAL:** European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire
- **BEHAVIORAL:** Patient Post Intervention Survey

## Key facts

- **NCT ID:** NCT05579847
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-19
- **Primary completion:** 2024-01-07
- **Final completion:** 2024-11-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05579847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05579847, "Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05579847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*